Physician profile
Robert Carlson
NPI 1487632683
$755.39
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $24.91 · 2021: $127 · 2022: $227 · 2023: $194 · 2024: $21.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $162.56 | 2019-2023 | Euflexxa |
| Smith+Nephew, INC. | $136.75 | 2019-2023 | Evos, Trigen Intertan |
| Pacira Therapeutics, INC. | $104.28 | 2019-2021 | |
| Medartis INC. | $63.75 | 2022 | |
| Zimvie INC. | $51.98 | 2022 | |
| Arteriocyte Medical Systems, INC. | $51.60 | 2019-2021 | |
| Depuy Synthes Sales INC. | $30.23 | 2022-2023 | Monovisc, Orthovisc |
| Orthofix Medical, INC. | $25.75 | 2023 | Physio-Stim |
| Heron Therapeutics, INC. | $21.48 | 2024 | Zynrelef |
| Integra Lifesciences Corporation | $20.70 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Axogen | $18.02 | 2022 | |
| Avanos Medical | $16.67 | 2019 | |
| Horizon Therapeutics Plc | $14.79 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.44 | 2022 | |
| Merck Sharp & Dohme LLC | $13.64 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $8.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Carlson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.